3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
6
Neoplasm Metastasis
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Multiple Myeloma
2
Lymphoma, Follicular
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Thyroid cancer, follicular
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Spinocerebellar Degenerations
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Renal Insufficiency
1
Recurrence
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Malignant Solid Neoplasm
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Leukemia, Lymphoid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hepatic Insufficiency
1
Gallbladder Neoplasms
1
Digestive System Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Interventions
Gemcitabine
47
Cisplatin
32
pembrolizumab
28
Paclitaxel
13
Docetaxel
13
avelumab
12
Mitomycin
12
atezolizumab
11
Nivolumab
11
Cystectomy
10
Carboplatin
9
durvalumab
7
Sunitinib
7
apaziquone
6
Doxorubicin
6
BCG Vaccine
6
5-aminolevulinic acid hexyl ester
6
Vinblastine
5
Radiation
5
Platinum
5
Methotrexate
5
Magnetic Resonance Spectroscopy
5
Albumin-Bound Paclitaxel
5
Taxes
4
Standard of Care
4
Sorafenib
4
Radiotherapy
4
Fluorouracil
4
Erlotinib Hydrochloride
4
1,2-diaminocyclohexaneplatinum II citrate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urinary Bladder Neoplasms
×
copanlisib
×
Clear all
No trials found.